Monkeypox treatment options: current status of antiviral drugs - a correspondence.
作者信息
Ganapthy Dhanraj, Sekaran Saravanan, Rajamani Sekar Suresh Kumar
机构信息
Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute for Medical and Technical Sciences, Chennai, Tamil Nadu, India.
College of Natural Sciences, Arba Minch University, SNNPR, Ethiopia.
出版信息
Int J Surg. 2023 Mar 1;109(3):562-563. doi: 10.1097/JS9.0000000000000147.
Abstract
摘要
相似文献
1
Monkeypox treatment options: current status of antiviral drugs - a correspondence.猴痘治疗方案：抗病毒药物的现状——一封通信
Int J Surg. 2023 Mar 1;109(3):562-563. doi: 10.1097/JS9.0000000000000147.
2
Functional characteristics of plitidepsin as an antiviral treatment against monkeypox virus infection.普利替德生作为抗猴痘病毒感染抗病毒治疗的功能特性
Antiviral Res. 2025 Jul 15;241:106238. doi: 10.1016/j.antiviral.2025.106238.
3
Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance.重新利用药物进行协同联合治疗以对抗猴痘病毒对特考韦瑞的耐药性。
Viruses. 2025 Jan 13;17(1):92. doi: 10.3390/v17010092.
4
Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects.治疗猴痘的临床管理、抗病毒药物和免疫疗法。当前知识与未来前景的最新情况
Int J Surg. 2022 Sep;105:106847. doi: 10.1016/j.ijsu.2022.106847. Epub 2022 Aug 19.
5
Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment.2022年至2025年猴痘疫情最新情况：关于其并发症、传播、诊断和治疗的全面综述
Viruses. 2025 May 25;17(6):753. doi: 10.3390/v17060753.
6
A comprehensive review of current diagnostic techniques for Monkeypox virus detection.猴痘病毒检测当前诊断技术的全面综述。
Biologicals. 2025 May 7;91:101841. doi: 10.1016/j.biologicals.2025.101841.
7
Coinfections with monkeypox virus and varicella-zoster virus: a systematic review of case reports and case series.猴痘病毒与水痘-带状疱疹病毒合并感染：病例报告和病例系列的系统评价
Arch Virol. 2025 Jul 18;170(8):183. doi: 10.1007/s00705-025-06359-6.
8
Is a 2-week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?
J Med Virol. 2024 May;96(5):e29617. doi: 10.1002/jmv.29617.
9
Recent advances and perspectives in therapeutics for mpox.猴痘治疗的最新进展与展望
Bioorg Med Chem Lett. 2025 Dec 1;128:130330. doi: 10.1016/j.bmcl.2025.130330. Epub 2025 Jul 11.
10
Unravelling the Treatment Strategies for Monkeypox Virus: Success and Bottlenecks.揭示猴痘病毒的治疗策略：成功与瓶颈
Rev Med Virol. 2025 Jul;35(4):e70051. doi: 10.1002/rmv.70051.
引用本文的文献
1
Phylogenetic analyses of the spread of Clade I MPOX in African and non-African nations.非洲和非非洲国家中I类猴痘病毒传播的系统发育分析。
Virus Genes. 2025 Jun;61(3):265-276. doi: 10.1007/s11262-025-02138-2. Epub 2025 Feb 12.
2
Navigating monkeypox: identifying risks and implementing solutions.应对猴痘：识别风险并实施解决方案。
Open Vet J. 2024 Dec;14(12):3144-3163. doi: 10.5455/OVJ.2024.v14.i12.1. Epub 2024 Dec 31.
3
The Human Monkeypox Virus and Host Immunity: Emerging Diagnostic and Therapeutic Challenges.人类猴痘病毒与宿主免疫：新出现的诊断和治疗挑战
Infect Disord Drug Targets. 2025;25(2):e18715265309361. doi: 10.2174/0118715265309361240806064619.
本文引用的文献
1
Monkeypox: A clinical update for paediatricians.猴痘：儿科医生的临床更新。
J Paediatr Child Health. 2022 Sep;58(9):1532-1538. doi: 10.1111/jpc.16171. Epub 2022 Aug 18.
2
Monkeypox - An emerging pandemic.猴痘——一种新出现的大流行病。
IDCases. 2022 Jul 26;29:e01587. doi: 10.1016/j.idcr.2022.e01587. eCollection 2022.
3
Prevention and Treatment of Monkeypox.猴痘的预防与治疗。
Drugs. 2022 Jun;82(9):957-963. doi: 10.1007/s40265-022-01742-y. Epub 2022 Jun 28.
4
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.特考韦瑞玛治疗天花概述及拓展的抗正痘病毒应用。
Expert Rev Anti Infect Ther. 2021 Mar;19(3):331-344. doi: 10.1080/14787210.2020.1819791. Epub 2020 Sep 15.
5
Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.评估一种用于已消除人类疾病的药物：美国食品和药物管理局对特考韦瑞玛特治疗天花的审评。
Lancet Infect Dis. 2019 Jun;19(6):e221-e224. doi: 10.1016/S1473-3099(18)30788-6. Epub 2019 Mar 7.
6
Oral Tecovirimat for the Treatment of Smallpox.口服特考韦瑞玛用于天花的治疗。
N Engl J Med. 2018 Jul 5;379(1):44-53. doi: 10.1056/NEJMoa1705688.
7
Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox.布林西多福韦的短期临床安全性概况：在天花治疗中具有良好的效益风险比。
Antiviral Res. 2017 Jul;143:269-277. doi: 10.1016/j.antiviral.2017.01.009. Epub 2017 Jan 14.
8
Pharmacokinetic comparison of a single oral dose of polymorph form i versus form V capsules of the antiorthopoxvirus compound ST-246 in human volunteers.在人类志愿者中比较单剂量口服 I 型多晶型和 V 型胶囊的抗正痘病毒化合物 ST-246 的药代动力学。
Antimicrob Agents Chemother. 2012 Jul;56(7):3582-6. doi: 10.1128/AAC.06090-11. Epub 2012 Apr 23.
9
Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox.评估疾病和病毒生物标志物作为治疗干预呼吸道猴痘的触发因素-天花的动物模型。
Antiviral Res. 2012 Apr;94(1):44-53. doi: 10.1016/j.antiviral.2012.02.005. Epub 2012 Feb 18.
10
Development of CMX001 for the Treatment of Poxvirus Infections.用于治疗痘病毒感染的CMX001的研发
Viruses. 2010 Dec;2(12):2740-2762. doi: 10.3390/v2122740.
Zotero 插件